KTC
MRNA icon

Kistler-Tiffany Companies’s Moderna MRNA Stock Holding History

Kistler-Tiffany Companies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$33K Buy
272
+50
+23% +$6.67K 0.01% 542
2023
Q1 		$34.1K Hold
222
– – 0.01% 476
2022
Q4 		$39.9K Sell
222
-123
-36% -$20.1K 0.01% 450
2022
Q3 		$41K Hold
345
– – 0.01% 402
2022
Q2 		$49K Sell
345
-8
-2% -$1.14K 0.01% 380
2022
Q1 		$61K Hold
353
– – 0.01% 367
2021
Q4 		$90K Buy
353
+15
+4% +$4.39K 0.02% 308
2021
Q3 		$130K Buy
338
+8
+2% +$2.95K 0.03% 234
2021
Q2 		$78K Buy
330
+22
+7% +$3.93K 0.02% 306
2021
Q1 		$40K Buy
308
+160
+108% +$23.2K 0.01% 362
2020
Q4 		$15K Hold
148
– – ﹤0.01% 459
2020
Q3 		$10K Buy
+148
New +$10.3K ﹤0.01% 473

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kistler-Tiffany Companies's MRNA Position: Q2 2023 in Review

Kistler-Tiffany Companies increased its Moderna (MRNA) stake by 23% in Q2 2023, buying an estimated $6.67K and bringing the position to 272 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #542.

Kistler-Tiffany Companies first reported a position in MRNA in Q3 2020 and has held it in 12 quarters since. The position peaked at $130K in Q3 2021. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Kistler-Tiffany Companies held 272 shares of Moderna worth $33K as of Q2 2023.
  • Kistler-Tiffany Companies bought 50 Moderna shares in Q2 2023, an estimated $6.67K.
  • Moderna made up 0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #542 holding.
  • Kistler-Tiffany Companies first reported a position in Moderna in Q3 2020 and has held it in 12 quarters since.
  • Kistler-Tiffany Companies's Moderna position peaked at $130K in Q3 2021.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.